Chemomab Therapeutics
CMMBInsider trades and stock quote 2023-2025
All insider trades at Chemomab Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 1/3/2023 | Sell | Orbimed Israel Gp Ltd. | Ten Percent Owner | $3.9 | $1,207,759 |
| 1/3/2023 | Sell | Mor, George Adi | Chief Scientific Officer | $5.0 | $69,369 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)